BlackRock, Inc. and its funds have increased their ownership in Orion Corporation to over 5% of the company's total shares as of June 10, 2026. This change was disclosed under the Finnish Securities Market Act, indicating BlackRock's growing investment in the Nordic pharmaceutical company. Orion is known for its focus on oncology and pain therapies and reported net sales of EUR 1.89 billion in 2025. The increased stake by a major global investor like BlackRock could influence Orion's market perception and future strategic moves.
Core AI Holdings Inc. introduced HomeGPT, an AI-powered app for home design and renovation that lets users create and modify designs from a single photo. The launch follows a $5.4 million registered direct offering, which caused the stock to fall due...
SpaceX is preparing to price its IPO around $135 per share, valuing the company in the trillions and creating the first major public benchmark for the commercial space sector. This public valuation will influence how investors assess all space-relate...
Artificial Agency, an AI company specializing in generative behavior for gaming, appointed Greg Canessa as Chief Operating Officer. Canessa, a veteran with over 25 years in the gaming industry, will focus on expanding the commercial reach of the comp...
Evolution Metals & Technologies Corp. has achieved quality certification from two global Tier-1 OEMs for six grades of high-performance sintered NdFeB rare earth magnets produced at commercial scale in Korea. This certification positions EM&T as a cr...
21Shares, a leading issuer of crypto ETFs, was named to the inaugural Fortune Crypto 100 list, recognizing its innovation and influence in digital assets. The company recently launched THYP, the first Hyperliquid ETF available to U.S. investors, expa...
